JZJun Zhang

Jun Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jun Zhang has a total of 54 co-authors. Here are the top co-authors by number of shared publications:

  • Haotian Yang

    Heart Center, Shanghai Tenth People’s Hospital, School of Medicine Tongji University Shanghai China

    6 shared publications
  • Dongdong Zhao

    Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China

    4 shared publications
  • Shuang Li

    Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China

    3 shared publications
  • Weilun Meng

    Heart Center, Shanghai Tenth People’s Hospital, School of Medicine Tongji University Shanghai China

    3 shared publications
  • Yawei Xu

    Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China

    3 shared publications
  • Yixing Zheng

    Heart Center, Shanghai Tenth People’s Hospital, School of Medicine Tongji University Shanghai China

    3 shared publications

Latest Publications

  • Open Access

    Patients With Larger Left Atrial Appendage Orifice Presented Worse Prognosis Contributed by Acute Heart Failure After Left Atrial Appendage Closure

    by Zhongyuan Ren, Yixing Zheng, Jingying Zhang, Haotian Yang, Jiayu Wu, Hailing Li, Rong Guo, Weilun Meng, Jun Zhang, Hui Sun, et al.

    Background: Left atrial appendage (LAA) closure (LAAC) could prevent stroke in patients with atrial fibrillation. However, LAAC may impair the compliance of the left atrium and result in poor prognosis. This study aimed to comparatively evaluate the prognosis of LAAC among patients with different sizes of LAA orifice. Methods and Results: Three hundred two consecutive patients who underwent successful LAAC were included and divided into 4 groups based on LAA orifice size that was measured using transesophageal echocardiography. Clinical outcomes including thromboembolic events, major cardiocerebrovascular adverse events, and acute heart failure (AHF) were compared among 4 quartile groups and between propensity‐score matched groups of large and small LAAs. Through follow‐up of 39.6±8.4 months, survival of thromboembolic events was similar. Survival of major cardiocerebrovascular adverse events was significantly lower in the group with the largest LAA orifice (log‐rank P P =0.009). A large LAA orifice (by cutoff) could predict major cardiocerebrovascular adverse events (hazard ratio, 3.749 [95% CI, 2.074–6.779]) in most patients, except for subgroups of those aged P =0.010). Conclusions: Patients with a larger LAA orifice presented a worse prognosis after LAAC, including a higher incidence of AHF. A large LAA orifice could predict a post‐LAAC AHF event in most patients, except for young patients, patients with paroxysmal atrial fibrillation, and/or with failed rhythm/rate control. Registration: URL: clinicaltrials.gov ; Unique identifier: NCT04185142.


  • Open Access

    Pregnancy outcomes in women with moderate and severe aortic stenosis

    by Dong Yang, Hao-Feng Zhang, Zhao-Liang Bao, He Zhao, Yan-Na Li, Jun Zhang

    Background: Aortic stenosis (AS) is one of the degenerative heart lesions mainly resulting from congenital defects and rheumatic diseases. This study aimed to determine maternal and fetal outcomes in pregnant women with moderate and severe AS. Methods: The clinical data of 26 pregnant women with AS treated between 2007 and 2019 in Beijing Anzhen Hospital were collected and retrospectively analyzed. Results: AS was diagnosed before pregnancy or after pregnancy in 16 (61.5%) and 10 (38.5%) patients, respectively. Except the peak velocity and mean pressure gradient, no significant difference in baseline cardiac parameters between the patients with moderate AS and severe/very severe AS, such as AS locations, previous heart failure symptoms, and heart function was seen. Heart failure and arrhythmia were complicated in 14 (53.8%) and 6 (23.1%) pregnancies, respectively. The rate of Caesarean deliveries was 85.7% in the patients with severe/very severe AS and 58.3% in the patients with moderate AS. There was no neonatal asphyxia or neonatal death in the cohort. Conclusions: The results of our study indicate the pre-conceptional evaluation and counseling should be performed in women with AS and those with symptomatic and severe AS are recommend to take cardiac surgery as appropriate before pregnancy.


  • Open Access

    Cryoablation Combined with Left Atrial Appendage Closure: A Safe and Effective Procedure for Paroxysmal Atrial Fibrillation Patients

    by Zhongyuan Ren, Jun Zhang, Mengyun Zhu, Dongdong Zhao, Shuang Li, Haotian Yang, Yixing Zheng, Weilun Meng, Jingying Zhang, Yawei Xu

    Background. Catheter ablation combined with left atrial appendage closure (LAAC) was reported as a feasible strategy for atrial fibrillation (AF) patients with high risk of stroke or contraindications of oral anticoagulants. We aimed to observe the short-term safety and efficacy of combining cryoballoon ablation (CBA) with LAAC in paroxysmal (PAF) patients. Method and Results. From Jan 2016 to Dec 2017, 304 patients diagnosed with nonvalvular, drug-refractory PAF were included, who underwent either CBA alone (n = 262) or combined procedure (n = 42). Instant pulmonary vein isolation (PVI) with CBA was achieved in all patients, while successful LAAC achieved in 41 (97.6%) of combined procedure patients. 1-year freedom of AF rate was lower in combined procedure group (84.7% vs 70.7%, p=0.04), with unadjusted hazard ratio (HR = 1.97) and 95% confidence interval (CI) 1.03–3.77. However, the multivariate COX model revealed left atrial diameter (p=0.002, HR = 1.10, and 95% CI 1.04, 1.17), rather than procedure type (p=0.51, HR = 1.34, and 95% CI 0.57, 3.17), was the predictor for freedom of AF. Only 2 patients in the CBA group had stroke, contributing to the nonsignificant higher stroke incidence (p=1.00). Transoesophageal echochardiography (TEE) achieved in 35 patients (83.3%) showed complete occlusion with no obvious residual flow (>3 mm), Device-related thrombosis, or pericardial perfusion. All-cause mortality, rehospitalization, and complication rates were similar. Conclusion. Combining CBA with LAAC in a single procedure is a feasible strategy for PAF patients, with comparable short-term safety and efficacy to CBA alone.


  • Efficacy and safety of cryoballoon ablation for Chinese patients over 75 years old: A comparison with a younger cohort

    by Jun Zhang, Zhongyuan Ren, Songyun Wang, Jingying Zhang, Haotian Yang, Yixing Zheng, Weilun Meng, Dongdong Zhao, Yawei Xu

    Introduction: Cryoballoon ablation (CBA) results in satisfactory outcomes for drug‐resistant atrial fibrillation (AF) patients. However, the efficacy and safety of CBA have not yet been tested in the Chinese elderly population. Therefore, this study compared the recurrence of AF and complications of CBA in patients ≥75 years and P < .01) and HAS‐BLED (1.8 ± 0.8 vs 2.0 ± 0.8, P = .01) scores were significantly higher in the elderly group. The instant pulmonary vein isolation success rate was comparable (99.11% younger vs 98.98% older, P = .99). After a mean follow‐up time of 12.8 ± 9.6 months, the 1‐year freedom from AF rate was 80.6% vs 85.8% in the older and younger groups, respectively, while the survival analysis showed a nonsignificant difference in the rate of freedom from AF (log‐rank P = .46). Cox regression showed that age was not a predictive factor for AF recurrence and was not dichotomized (hazard ratio [HR] = 0.868, 95% confidence interval [CI] 0.509‐1.481; P = .6046) or continuous (HR = 0.990, 95% CI, 0.968‐1.012, P = .3642). Similar complications rates were observed, including stroke (1.0% younger vs 0.93% older, P = .95) and major hemorrhagic events (1.2% younger vs 0% elder, P = .25).Conclusions: The efficacy and safety profiles of CBA in patients older than 75 years are comparable with those in younger patients.


  • Rs4968309 in Myosin Light Chain 4 (MYL4) Associated With Atrial Fibrillation Onset and Predicts Clinical Outcomes After Catheter Ablation in Atrial Fibrillation Patients Without Structural Heart Disease

    by Yuan Zhong, Kai Tang, Hailing Li, Dongdong Zhao, Wenxin Kou, Shaojie Xu, Jun Zhang, Haotian Yang, Shuang Li, Rong Guo, et al.

    Background: Atrial fibrillation (AF) is the most common arrhythmia with serious complications and a high rate of recurrence after catheter ablation. Recently, mutation of MYL4 was reported as responsible for familial atrial cardiomyopathy and AF. This study aimed to determine the association between polymorphism in MYL4 with the onset and recurrence of AF. Methods and Results: A total of 7 single-nucleotide polymorphisms were selected by linkage disequilibrium and genotyped in 510 consecutive AF patients and 192 controls without structural heart disease. A total of 246 AF patients who underwent cryoballoon ablation had a 1-year scheduled follow-up study for AF recurrence. C allele and CC genotype of rs4968309 and A allele of rsl 515751 were associated with AF onset both before and after adjustment of covariation (age, sex, hypertension, and diabetes). AF type and left atrial size were different among the genotypes of rs4968309. Moreover, CC genotype of rs4968309 increased susceptibly of AF recurrence after cryoballoon ablation. The prevalence of hypertension was associated with rsl 515752, and left atrial size was associated with the genotype of rs2071438. Conclusions: C allele and CC genotype of rs4968309 in MYL4 were associated with AF onset and recurrence. Moreover, the A allele of rs1515751 had a significant association with AF onset. The polymorphisms of MYL4 can predict AF onset and prognosis after ablation in AF patients without structural heart disease.


  • Impact of Stable Coronary Artery Disease on the Efficacy of Cryoballoon Ablation for the Atrial Fibrillation

    by Lu Liu, Dongdong Zhao, Jun Zhang, Haotian Yang, Fuad A. Abdu, Rong Guo, Shuang Li, Kai Tang, Hailing Li, Wenliang Che, et al.


  • Open Access

    Pentraxin-3 Levels Relate to the Wells Score and Prognosis in Patients with Acute Pulmonary Embolism

    by Haotian Yang, Jun Zhang, Ying Huan, Yawei Xu, Rong Guo

    Objective. To investigate the value of the PTX-3 test in evaluating the prognosis of acute pulmonary embolism (APE). Method. 117 APE patients were selected and divided into two groups according to plasma PTX-3 levels, including the group in which PTX−3≥3.0 ng/mL (n=42) and the group in which PTX−3<3.0 ng/mL (n=75). Patients were stratified into high-risk, medium-risk, and low-risk groups according to the Wells scores, and the PTX-3 levels were compared among the groups. Patients had been followed-up as well. Results. According to the Wells scores, 11 patients were classified as high-risk (9.4%) and 68 were medium-risk (58.1%), while 38 were low-risk (32.5%). The PTX-3 levels in different risk groups were statistically different (all P<0.05). During the follow-up period, 6 deaths occurred in the group with elevated PTX-3 (≥3.0 ng/mL), while 2 deaths occurred in the group with nonelevated PTX-3 (<3.0 ng/mL). The difference between the two groups was statistically significant (P<0.01). 13 patients were hospitalized due to recurrent pulmonary embolism, of which 12 were in the group with elevated PTX-3 (≥3.0 ng/mL), while 1 patient was in the group with nonelevated PTX-3 (<3.0 ng/mL). The difference was statistically significant (P<0.01). Conclusion. The plasma PTX-3 level in APE patients is correlated with PE risk stratification. There is a significant correlation between PTX-3 levels and PE-related cardiac deaths, as well as the prognosis of recurrent PE. PTX-3 can be used as a clinical indicator of PE prognosis.


  • Comparison of ankle-brachial index and upstroke time in association with target organ damage: the Northern Shanghai Study

    by Shikai Yu, Yuyan Lu, Jing Xiong, Jiadela Teliewubai, Chen Chi, Hongwei Ji, Yiwu Zhou, Ximin Fan, Jun Zhang, Jacques Blacher, et al.